ESC 365 - Doctor Fernando Scudiero

Speaker illustration

Doctor Fernando Scudiero

Bolognini Hospital, Seriate (Italy)

Presentations Articles

Dual antiplatelet therapy with 3rd generation P2Y12 inhibitors in STEMI patients: impact of Body Mass Index on high on-treatment platelet reactivity

Event: ESC Congress 2021 - The Digital Experience

Topic: Antiplatelet Drugs

Session: Pharmacology and pharmacotherapy e-posters

Hyperthyroidism in Takotsubo syndrome: prevalence, clinical features and long-term outcomes.

Event: ESC Congress 2020

Topic: Takotsubo Cardiomyopathy

Session: Evolving Concepts in MINOCA

Platelet reactivity in Hepatitis C virus infected patients on dual antiplatelet therapy for acute coronary syndrome

Event: ESC Congress 2019

Topic: Pharmacotherapy

Session: Acute Coronary Syndromes - Treatment antiplatelet

Percutaneous coronary intervention with 2nd generation drug eluting stent versus coronary artery bypass grafting in patients with unprotected left main disease: clinical outcome from a referral center

Event: ESC Congress 2019

Topic: Revascularisation

Session: Acute coronary syndrome - Procedural devices

Discriminatory ability of GRACE risk score to predict outcomes in patients with Takotsubo syndrome

Event: ESC Congress 2018

Topic: Takotsubo Cardiomyopathy

Session: Specials in cardiology: obstructive sleep apnea and Takotsubo syndrome

Relationship between uric acid and contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention: a meta-analysis and meta-regression

Event: ESC Congress 2017

Topic: CAD and comorbidities

Session: CAD and comorbidities

Discriminatory ability of CHA2DS2-VASc score to predict residual platelet reactivity and outcomes in patients with acute coronary syndrome

Event: ESC Congress 2017

Topic: Thrombosis and platelets

Session: Acute coronary syndromes: the full picture

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources